1 Open 2 Complete Did the speakers disclose their conflicts of interest (financial relationships with industry) verbally? * Yes No Not applicable I did not see this session Were the presentations free of commercial bias? * Yes No Not applicable If you answered "No" above, please explain what bias you detected. * Delivery of content was effective. * Strongly Agree Agree Neutral Disagree Strongly Disagree N/A Quality of content was high. * Strongly Agree Agree Neutral Disagree Strongly Disagree N/A Content was relative to practice. * Strongly Agree Agree Neutral Disagree Strongly Disagree N/A Presentation time was adequate for material to be covered. * Strongly Agree Agree Neutral Disagree Strongly Disagree N/A To what extent was the following learning objective met: * Apply advanced gynecologic oncology medical knowledge to interpret evolving treatment, including chemotherapy, immunotherapy, and antibody-drug conjugates (ADC), and procedural interventions, to support evidence-based patient management. Exceeds the objective Fully meets the objective Partially met, with minor critiques Not met To what extent was the following learning objective met: * Interpret diagnostic tools and clinical data—including diagnostic imaging and cytopathology, to inform treatment planning and patient monitoring. Exceeds the objective Fully meets the objective Partially met, with minor critiques Not met To what extent was the following learning objective met: * Demonstrate clinical reasoning and practice-based strategies in the prevention, recognition, and management of treatment‑related toxicities and symptoms, including dermatologic, pulmonary, gastrointestinal, neurologic, and menopausal complications, using diagnostic grading criteria and evidence‑based interventions. Exceeds the objective Fully meets the objective Partially met, with minor critiques Not met Please provide any additional comments. Leave this field blank
